Fragmentation of human cardiac troponin T after acute myocardial infarction

Area of Science:

• Biochemistry
• Cardiology
• Proteomics

Background:

• Cardiac troponin T (cTnT) is a key biomarker for diagnosing acute myocardial infarction (MI).
• Proteolytic degradation of cTnT in patient blood can impact diagnostic accuracy.
• Limited data exists on the extent and locations of cTnT proteolysis post-MI.

Purpose of the Study:

• To identify and quantify major cTnT fragments in the blood of MI patients.
• To determine the primary sites of cTnT degradation.
• To assess the temporal changes in cTnT fragment abundance after MI.

Main Methods:

• Analysis of serial plasma samples from 37 MI patients collected 2-37 hours post-MI.
• Western blotting and immunofluorescence assays utilizing cTnT epitope-specific monoclonal antibodies.
• Characterization of cTnT fragments based on molecular mass and antibody binding sites.

Main Results:

• Twenty-three distinct cTnT proteolytic fragments (8-37 kDa) were identified in MI patient blood.
• Major degradation sites were mapped between amino acid residues 68-69 and 189-223.
• An increase in central cTnT fragments was observed early post-MI, while C-terminal fragments remained stable.

Conclusions:

• cTnT undergoes progressive degradation into multiple fragments following MI.
• The N-terminal region of cTnT (approx. aar 69-158) is a potential target for developing improved total cTnT assays.
• Characterizing cTnT fragmentation patterns can refine diagnostic strategies for acute myocardial infarction.